Difference between revisions of "OHSU Research Ideas"

From Seth's Wiki
Jump to navigation Jump to search
Line 11: Line 11:
  
 
==Good==
 
==Good==
−
* Does change in PPV/CO after SCD activation predict fluid responsiveness and how does it compare to SLR?
+
* [[SCD Fluid Bolus|Does change in PPV/CO after SCD activation predict fluid responsiveness and how does it compare to SLR?]]
 
* Does sugammadex interfere with HRT in post-menopausal and/or lactating women? (0 articles mentioning both Sugammadex and Menopause)
 
* Does sugammadex interfere with HRT in post-menopausal and/or lactating women? (0 articles mentioning both Sugammadex and Menopause)
 
* EEG/MEP/SSEP patterns in monkeys/humans taking THC vs controls
 
* EEG/MEP/SSEP patterns in monkeys/humans taking THC vs controls
Line 59: Line 59:
 
* Jeff Davis
 
* Jeff Davis
 
* Brandon Togioka
 
* Brandon Togioka
−
 
−
=SCD hemodynamic effects=
 
−
{| class="wikitable"
 
−
|+ Caption text
 
−
|-
 
−
! Reference !! Population !! Intervention !! Comparator !! Outcome
 
−
|-
 
−
| [https://www.ima.org.il/FilesUploadPublic/IMAJ/0/384/192227.pdf Moady et al IMAJ 2019] || Healthy volunteers and HFrEF patients || Pneumatic sleeve (PS) compression devices applied to both legs from toe to thigh and inflated to a pressure of 50 or 80 mmHg. the same method does not exacerbate symptoms and increases CO via an increase in SV, decreases SVR, and has no effect on HR (see ref 17). || Example || In healthy volunteers, there was increased CO, decrease SVR, and have no effect on HR (see ref 16). HFrEF patients who were medically optimized had '''no change in any hemodynamic parameter after 60 minutes of PS application''', and that they tolerated it well without any increase in their BNP.
 
−
|-
 
−
| [https://pubmed.ncbi.nlm.nih.gov/25038262/#:~:text=There%20was%20no%20detrimental%20effect,and%20a%20reduction%20in%20SVR. Bickel et al J of Card Failure 2014] || Patients with HFrEF (mean LVEF 30%) || ISPC devices applied to both legs and cycled every 2 min for 40 min. || Example || Increased CO, SV, and decreased SVR w/o any effect on HR and without causing signs or symptoms of heart failure exacerbation. CVP and atrial size increased during ISPC activation.
 
−
|-
 
−
| [https://pubmed.ncbi.nlm.nih.gov/31578774/ Gibbons et al Experimental Physiology 2019] || 14 healthy university students || Four 3 minute trials of orthostatic maneuvers (stand-to-squat or thigh cuff compression/release) were done in random order with half of the trials involving ISPC (5 cuffs, peristaltic motion, applied over 200 ms, 65 mmHg, timed to local diastolic phase) of the lower extremity timed to counteract orthostatic changes (return to standing or after thigh-cuff release). Hemodynamic parameters (superficial femoral artery, MAP, Doppler ultrasound cardiac output, total peripheral resistance, middle cerebral artery blood velocity (MCAv), and cerebral tissue saturation index) were measured non-invasively before, during, and after || Example || Decreased TPR, heart rate; increased CO (via increased SV), TSI, and MCAv
 
−
|-
 
−
| [https://pubmed.ncbi.nlm.nih.gov/24020667/ Helmi et al Future Cardiology 2013] || Example || Example || Example || Example
 
−
|-
 
−
| [https://pubmed.ncbi.nlm.nih.gov/21307764/ Kiefer et al Anesthesiology 2011] || Example || Example || Example || Example
 
−
|-
 
−
| [https://pubmed.ncbi.nlm.nih.gov/20622680/ Kwak et al J of Neurosurgical Anesthesiology 2011] || Example || Example || Example || Example
 
−
|-
 
−
| [https://pubmed.ncbi.nlm.nih.gov/20511029/ Kwak et al Arthroscopy 2010] || Example || Example || Example || Example
 
−
|-
 
−
| [https://pubmed.ncbi.nlm.nih.gov/18761240/ Fanelli et al J of Clin Anesthesia 2008] || Example || Example || Example || Example
 
−
|-
 
−
| [https://pubmed.ncbi.nlm.nih.gov/18219162/ Sohn et al Circulation J 2008] || Example || Example || Example || Example
 
−
|}
 

Revision as of 23:04, 5 August 2024

https://www.mediawiki.org/wiki/Extension:CollapsibleSections

Ideas

QI

  • What is the optimal number of evals for residents and attending to fill out? Would having fewer result in higher quality? How often do residents and attendings look at their medhub evals? Does anyone find them useful? If they are not useful, lets stop doing them, or tweak it (to be less frequent)
  • Having anesthesia residents/attendings assigned some complex cases 1 month in advance and then have them do the pre-anesthetic eval and interim optimization for that patient. Perhaps even a post-op follow-up call or visit.
  • Low-flow anesthesia real-time decision support built into EPIC (or laminated card reminder placed on workstations). See Baby Miller pg. 877.
  • Is there anyway to educate providers on how (or if) anesthetic management decisions affect the bill the patient sees?
  • Recycling and waste sortage in the OR. Also, getting rid of ProVu!

Good

  • Does change in PPV/CO after SCD activation predict fluid responsiveness and how does it compare to SLR?
  • Does sugammadex interfere with HRT in post-menopausal and/or lactating women? (0 articles mentioning both Sugammadex and Menopause)
  • EEG/MEP/SSEP patterns in monkeys/humans taking THC vs controls
  • Buprenorphine for induction or acute pain treatment in perioperative setting
  • Surgical TAP block vs US guided
  • Choice of anesthetic for cancer resection. Is TIVA superior to inhaled anesthesia for recurrence free survival in cancer surgery?
  • Xenon recycling (7 relevant papers)
  • Yohimbine for precedex reversal
  • Can ET O2 and FiO2 gradient be used to calculate VO2?
  • Does normocytic hemodilution reduce RBC transfusion?
  • What do we know about the very low frequency EEG power bands? i.e. the stuff that is less than 0.2 Hz and is usually filtered out. Analogous to looking at the tides when everyone else is looking at the waves.
  • Young blood transfusions.

Very Ambitious, But Still Cool

  • NIBP monitoring from head/neck
  • Can you modulate the strength of the Bohr effect to extract more hemoglobin from oxygen (thus prolonging apnea time before desaturation)? Humpback whales (and very small animals) have a much stronger Bohr effect, presumably from hemoglobin mutations. One approach would be non-immunogenic artificial hemoglobin proteins (made with CRISPR and perhaps packaged into empty RBCs?), another option would be some drug that modulates the Bohr effect on human Hgb.
  • Better way of determining fluid status
  • Novel reversal agents (e.g. volatile anesthetics, propofol, precedex)
  • Permanently inhibit a nerve to prevent phantom pain after amputation.
  • Reversible chemical/optical/electromagnetic knockdown/inhibition/interference of pain nuclei/DRG/dorsal column/STT activity in rodents/primates. https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejp.1136
  • Fentanyl patch instead of remifentanil infusion? What other anesthetics could you deliver via patch? Could you do a patch induction for Peds? There is no remifentanil or sufentanil patch.
  • What is the MoA of APAP?
  • Transfusion thresholds

Already Done

Not Super Exciting/Impactful

  • Which findings on the preop note predict pressors use during the case?
  • EPIC timeline builder
  • Does setting realistic pain expectations in pre-op decrease self-reported pain scores in PACU?
  • Ultrasound vs blind A-line first attempt success rate and complications?
  • How do epidurals affect gastric emptying?

Resources

  • Schnell lab
  • Leimer/Lo lab (THC, NHPs)
  • Saugstad lab (EVs)
  • Schennings (Gas vs. TIVA risk of post-op delirium, assessed via CAM)
  • Schulman (interrogate ICDs for EMI after surgery)
  • Austin Peters
  • Selva Balkan
  • Dale Hodges
  • Liz Moss
  • Jeff Davis
  • Brandon Togioka
Retrieved from "http://www.sethvogel.com/wiki/index.php?title=OHSU_Research_Ideas&oldid=978"